Do you want to change careers? Are you absolutely sure?
From my own career change to the stories I hear from my clients and workshop students, often we think we want to change careers when the problem is our work environment instead. If you find yourself stuck, unsure what to do next, or t
Small capsemiconductor stock Diodes Incorporated (NASDAQ: DIOD) has produced a double top on its technical chart with shares just below breakout levels:
Small cap Diodes Incorporated is aStandard and Poors SmallCap 600 and Russell 3000 Index company thats a leading global manufacturer and supplier of high-quality application specific standard products within the broad discrete, logic,analog....More>>>
The U.S. dollar rallied against most of its main rivals Wednesday following the Federal Reserves policy statement. The central bank kept its interest rate on hold, but detailed that it would unwind its bloated post-financial-crisis balance sheet starting October.
Every month, $10 billion will be shed from the $4.5 trillion balance sheet, the Fed announced. Furthermore, the Feds interest-rate....More>>>
Succeeding 13 years of R&D with a commercial-level rare disease drug, Sarepta Therapeutics, Inc. (NASDAQ:SRPT) tees up to deliver on the latter half of its promise to provide the world with a DMD cure for sufferers that may be amenable to Exon 51 skipping, and otherwise. A result that would facilitate the first cure for DMD and sizable growth potential.
Microsoft Corporation can scale new highs if it’s latest initiatives pay off in the booming AR/VR market.
Of late, shares ofMicrosoft (NSDQ:MSFT) have been making new highs, with solid double-digit returns YTD, in contrastwith its past years. Microsoft’s cloud business, along with Office 365 and LinkedIn synergies are seen as major growth drivers. However,Microsoft which is....More>>>
If you have any challenges reading the charts in this article, check out the first article on quick and dirty discounts to book value for mortgage REITs. This piece is designed to be short and to emphasize providing easy charts that help investors identify opportunities for further inspection. Some of these mREITs recently reported their Q1 book value. The changes aren’t worked in yet, but....More>>>
The nations top CEOs stepped up their hiring and investment plans in the first quarter amid a burst of confidence overPresident Trumps pro-business agenda, showing no signs that early political roadblocks had dimmed their optimism.
Meanwhile, small business optimism pulled back slightly but remained near its recent record high.
CEOs are increasingly positive about the direction of....More>>>
Bond yields have been soaring for months and particularly since the presidential election. The 10-year Treasury yield is up nearly 70% from its mid-summer lows. Yet even after a run like that, the 10-year yield is still a pitiful 2.2%. Good luck living on that in retirement. Investors looking for retirement income are still going to have better luck with a portfolio of dividend stocks.
It would be fair to say biotech has had an interesting time of it over the course of the past 15 months. Except, of course, that biotech always has an interesting time of it. The go big or go home sector of the market attracts speculators, scientists, and unsavory characters, but also attracts people hoping for critical improvements to their healthcare options.
The following stocks were moving the Transportation sector today.
Some of the biggest gainers among Transportation stocks include:
American Midstreampartners LP (AMID): AMID stock is up 4.48% today. Pampa Energia S.A. (PAM): PAM stock is up 3.84% today. Danaos Corp (DAC): DAC stock is up 5.88% today. Golden Ocean Gp Cmn (GOGL): GOGL stock is up 3.06% today. Companhia Paranaense De....More>>>
Can we be honest here? It was yet another Warren Buffett shareholder weekend. That meant another year of Twitter pics of journos sticking mics in front of Buffett's face while he walked a convention floor holding a Dilly bar, another year of interviews of Buffett shareholders that have held the
The best investments are those where, opposite to popular opinion, one does not have to be the smartest person in the room. The best investments are ones where the odds of success are so far tilted to ones favor that even if so much can be wrong in one thesis, you still end up d
Along with the February traffic numbers, Delta Air Lines (NYSE:DAL) reported a key stat returned to flat after an extended period of negative prints. The stock, though, shook off the improving trend with an initial decline due to the weak market.
In the aftermath of Antares Pharma (ATRS) falling from $4.09 in mid-October to $1.58 by mid-November 2017 after it was learned that the FDA had issued a CRL for the company's TRT (testosterone replacement therapy) drug Xyosted, the stock has made a slow comeback beginning in December to a curren